Answers are grounded in this paper and cite their sources.
Hepatitis C virus (HCV) eradication using antiviral agents augments the metabolic profile. Changes in glycated hemoglobin (HbA1c) levels in chronic hepatitis C patients who receive glecaprevir/pibrentasvir (GLE/PIB) remain elusive.
No takes yet. Share an insight, caveat, or question.
Jang et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: